These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 20682012

  • 1. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
    Avery RK, Marty FM, Strasfeld L, Lee I, Arrieta A, Chou S, Tatarowicz W, Villano S.
    Transpl Infect Dis; 2010 Dec; 12(6):489-96. PubMed ID: 20682012
    [Abstract] [Full Text] [Related]

  • 2. Maribavir: a novel antiviral agent with activity against cytomegalovirus.
    Trofe J, Pote L, Wade E, Blumberg E, Bloom RD.
    Ann Pharmacother; 2008 Oct; 42(10):1447-57. PubMed ID: 18698013
    [Abstract] [Full Text] [Related]

  • 3. Phenotype and Genotype Study of Novel C480F Maribavir-Ganciclovir Cross-Resistance Mutation Detected in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.
    Santos Bravo M, Plault N, Sánchez Palomino S, Mosquera Gutierrez MM, Fernández Avilés F, Suarez Lledo M, Sabé Fernández N, Rovira M, Alain S, Marcos Maeso MÁ.
    J Infect Dis; 2021 Sep 17; 224(6):1024-1028. PubMed ID: 33475730
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263.
    Drugs R D; 2007 Sep 17; 8(3):188-92. PubMed ID: 17472414
    [Abstract] [Full Text] [Related]

  • 10. Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.
    Germi R, Mariette C, Alain S, Lupo J, Thiebaut A, Brion JP, Epaulard O, Saint Raymond C, Malvezzi P, Morand P.
    Antiviral Res; 2014 Jan 17; 101():57-61. PubMed ID: 24184983
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir.
    Chou S.
    Rev Med Virol; 2008 Jan 17; 18(4):233-46. PubMed ID: 18383425
    [Abstract] [Full Text] [Related]

  • 12. Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.
    Papanicolaou GA, Silveira FP, Langston AA, Pereira MR, Avery RK, Uknis M, Wijatyk A, Wu J, Boeckh M, Marty FM, Villano S.
    Clin Infect Dis; 2019 Apr 08; 68(8):1255-1264. PubMed ID: 30329038
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir.
    Boutolleau D, Burrel S, Agut H.
    Antiviral Res; 2011 Jul 08; 91(1):32-5. PubMed ID: 21570426
    [Abstract] [Full Text] [Related]

  • 15. Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir.
    Strasfeld L, Lee I, Tatarowicz W, Villano S, Chou S.
    J Infect Dis; 2010 Jul 01; 202(1):104-8. PubMed ID: 20504236
    [Abstract] [Full Text] [Related]

  • 16. Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?
    Monday LM, Keri V, Chandrasekar PH.
    Expert Opin Pharmacother; 2024 Apr 01; 25(6):685-694. PubMed ID: 38717943
    [Abstract] [Full Text] [Related]

  • 17. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP.
    Semin Respir Infect; 2002 Dec 01; 17(4):265-73. PubMed ID: 12497543
    [Abstract] [Full Text] [Related]

  • 18. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.
    Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L, Young JA, Rodriguez T, Maertens J, Schmitt M, Einsele H, Ferrant A, Lipton JH, Villano SA, Chen H, Boeckh M, Maribavir 1263-300 Clinical Study Group.
    Lancet Infect Dis; 2011 Apr 01; 11(4):284-92. PubMed ID: 21414843
    [Abstract] [Full Text] [Related]

  • 19. Maribavir (ViroPharma).
    Lu H, Thomas S.
    Curr Opin Investig Drugs; 2004 Aug 01; 5(8):898-906. PubMed ID: 15600248
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.